Gadoteridol is a gadolinium-based contrast agent (GBCA) belonging to the class of macrocyclic magnetic resonance imaging contrast media. It is primarily used to enhance the clarity and detail of magnetic… Read more

![Chemical structure of 1,4,7,10-Tetraaza-1,4,7-tris-(carboxymethyl)-11-oxo-bicyclo[8.2.2]tetradecanium Halide Salt](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F14710-Tetraaza-147-tris-carboxymethyl-11-oxo-bicyclo8.2.2tetradecanium-Halide-Salt.png&w=3840&q=75)





![Chemical structure of 1,4,7-Tris(carboxymethyl)-11-oxo-1,4,7,10-tetraazabicyclo[8.2.2]tetradecan-1-ium Chloride](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F147-Triscarboxymethyl-11-oxo-14710-tetraazabicyclo8.2.2tetradecan-1-ium-Chloride.png&w=3840&q=75)








![Chemical structure of 2,2'-(13-Oxo-1,4,7,10-tetraazabicyclo[8.2.1]tridecane-4,7-diyl)diacetic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F229312-33-8-22-13-Oxo-14710-tetraazabicyclo8.2.1tridecane-47-diyldiacetic-Acid.png&w=3840&q=75)




















![Chemical structure of Gadoteridol Related Compound C (1,4,7,10-Tetraaza-11-oxo-bicyclo[8.2.2]tetradecane-4,7-diacetic aci (1287664)](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F220182-19-4-Gadoteridol-Related-Compound-C-14710-Tetraaza-11-oxo-bicyclo8.2.2tetradecane-47-diacetic-aci-1287664.png&w=3840&q=75)


Gadoteridol is a gadolinium-based contrast agent (GBCA) belonging to the class of macrocyclic magnetic resonance imaging contrast media. It is primarily used to enhance the clarity and detail of magnetic resonance imaging (MRI) scans, aiding in the visualization and diagnosis of lesions and abnormalities in the central nervous system, including the brain and spine. Pharmaceutical laboratories and quality control facilities utilize reference standards of gadoteridol, its known impurities, related compounds, and stable isotope labelled versions to support rigorous analytical testing. These compounds are essential for accurate impurity profiling, the validation of analytical methods such as high-performance liquid chromatography, and ensuring regulatory compliance during drug development and batch release testing. By providing reliable markers for process-related and degradation impurities, these standards assist in maintaining consistent quality and safety throughout the lifecycle of the contrast agent.